title: [Reticulated telangiectasic erythema following morphine pump implantation].
abstract: BACKGROUND
  Reticulated telangiectasic erythema is a cutaneous complication reported after in the implementation of pacemakers and cardiac defibrillators. Here we report a case occurring after the implantation of a morphine pump.
  
  
  METHODS
  Reticulated and pigmented telangiectasic erythema was observed at the morphine pump implantation site in a 56-year-old man presenting chronic lower back pain.
  
  
  CONCLUSIONS
  To date, cutaneous telangiectasic erythema has been reported following implantation of cardiac defibrillators and pacemakers although the physiopathogenesis of the condition is poorly understood. An identical case was recently described following implantation of morphine pump, as in our case. We discuss hypotheses concerning the possible physiopathogenesis of such lesions.
authors.affiliation: Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, 1, rue Jean-Burguet, 33075 Bordeaux, France. brigitte.milpied@chu-bordeaux.fr
authors.forename: B
authors.initials: B
authors.lastname: Milpied-Homsi
authors.forename: C
authors.initials: C
authors.lastname: Bernier
authors.forename: M
authors.initials: M
authors.lastname: Meignier
authors.forename: J-F
authors.initials: JF
authors.lastname: Stalder
mesh_terms: D001284:Atrophy; D002908:Chronic Disease; D004890:Erythema / Q000209:etiology*; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000009:adverse effects*; D017116:Low Back Pain / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage; D009294:Narcotics / Q000008:administration & dosage; D011537:Pruritus / Q000209:etiology; D012867:Skin / Q000473:pathology; D013684:Telangiectasis / Q000209:etiology*
chemical_list: D009294:Narcotics; D009020:Morphine